Connecticut SB 48: AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

Status: FAV. RPT., TAB. FOR CAL., SEN. (as of 2019-05-21)

State: Connecticut · Session: 2019 · Bill: SB 48

Subjects: Drug manufacturers, Unfair or deceptive trade practices

Sponsors: Looney, Martin M.

View Connecticut SB 48 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.